BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30221579)

  • 1. Circulating Epithelial Cell Characterization and Correlation with Remission and Survival in Patients with Thyroid Cancer.
    Lin JD; Liou MJ; Hsu HL; Leong KK; Chen YT; Wang YR; Hung WS; Lee HY; Tsai HJ; Tseng CP
    Thyroid; 2018 Nov; 28(11):1479-1489. PubMed ID: 30221579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating epithelial cells as potential biomarkers for detection of recurrence in patients of papillary thyroid carcinoma with positive serum anti-thyroglobulin antibody.
    Li YR; Tseng CP; Hsu HL; Lin HC; Chen YA; Chen ST; Liou MJ; Lin JD
    Clin Chim Acta; 2018 Feb; 477():74-80. PubMed ID: 29229463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined analysis of circulating epithelial cells and serum thyroglobulin for distinguishing disease status of the patients with papillary thyroid carcinoma.
    Lin HC; Liou MJ; Hsu HL; Hsieh JC; Chen YA; Tseng CP; Lin JD
    Oncotarget; 2016 Mar; 7(13):17242-53. PubMed ID: 26684026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating epithelial cell counts for monitoring the therapeutic outcome of patients with papillary thyroid carcinoma.
    Tseng CP; Leong KK; Liou MJ; Hsu HL; Lin HC; Chen YA; Lin JD
    Oncotarget; 2017 Sep; 8(44):77453-77464. PubMed ID: 29100400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining tissue origin of circulating epithelial cells (CEC) in patients with differentiated thyroid cancer by real-time PCR using thyroid mRNA probes.
    Sorg S; Pachmann K; Brede-Hekimian K; Freesmeyer M; Winkens T
    Cancer Lett; 2015 Jan; 356(2 Pt B):491-5. PubMed ID: 25304372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of circulating tumor cells with podoplanin expression in patients with locally advanced or metastatic head and neck squamous cell carcinoma.
    Hsieh JC; Lin HC; Huang CY; Hsu HL; Wu TM; Lee CL; Chen MC; Wang HM; Tseng CP
    Head Neck; 2015 Oct; 37(10):1448-55. PubMed ID: 24844673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating epithelial cells in patients with thyroid carcinoma. Can they be identified in the blood?
    Winkens T; Pachmann K; Freesmeyer M
    Nuklearmedizin; 2013; 52(1):7-13. PubMed ID: 23254889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating epithelial cell enumeration facilitates the identification and follow-up of a patient with early stage papillary thyroid microcarcinoma: A case report.
    Hsieh CH; Lin HC; Huang SB; Hsueh C; Hsu HL; Wang HM; Wu MH; Tseng CP; Lin JD
    Clin Chim Acta; 2016 Feb; 454():107-11. PubMed ID: 26751809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumor cell enumeration for improved screening and disease detection of patients with colorectal cancer.
    Tsai WS; Hung WS; Wang TM; Liu H; Yang CY; Wu SM; Hsu HL; Hsiao YC; Tsai HJ; Tseng CP
    Biomed J; 2021 Dec; 44(6 Suppl 2):S190-S200. PubMed ID: 35292267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Podoplanin (PDPN) affects the invasiveness of thyroid carcinoma cells by inducing ezrin, radixin and moesin (E/R/M) phosphorylation in association with matrix metalloproteinases.
    Sikorska J; Gaweł D; Domek H; Rudzińska M; Czarnocka B
    BMC Cancer; 2019 Jan; 19(1):85. PubMed ID: 30654768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The utility of peripheral thyrotropin mRNA in the diagnosis of follicular neoplasms and surveillance of thyroid cancers.
    Milas M; Mazzaglia P; Chia SY; Skugor M; Berber E; Reddy S; Gupta M; Siperstein A
    Surgery; 2007 Feb; 141(2):137-46; discussion 146. PubMed ID: 17263967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer.
    Aliyev A; Soundararajan S; Bucak E; Gupta M; Hatipoglu B; Nasr C; Siperstein A; Berber E
    Surgery; 2015 Oct; 158(4):1089-93; discussion 1093-4. PubMed ID: 26212344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid-stimulating hormone receptor messenger ribonucleic acid measurement in blood as a marker for circulating thyroid cancer cells and its role in the preoperative diagnosis of thyroid cancer.
    Chia SY; Milas M; Reddy SK; Siperstein A; Skugor M; Brainard J; Gupta MK
    J Clin Endocrinol Metab; 2007 Feb; 92(2):468-75. PubMed ID: 17118994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of circulating thyroid cancer cells in patients with thyroid microcarcinomas.
    Novosel T; Ritter HE; Gupta M; Harvey A; Mitchell J; Berber E; Siperstein A; Milas M
    Surgery; 2009 Dec; 146(6):1081-9. PubMed ID: 19958935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demasking of epithelial cell adhesion molecule (EpCAM) on circulating epithelial tumor cells by Tween®20 treatment in breast cancer patients.
    Hekimian K; Stein EL; Pachmann U; Pachmann K
    Clin Chem Lab Med; 2012 Dec; 50(4):701-8. PubMed ID: 22505561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of peripheral thyrotropin receptor mRNA in follow-up of differentiated thyroid cancer.
    Milas M; Barbosa GF; Mitchell J; Berber E; Siperstein A; Gupta M
    Ann Surg Oncol; 2009 Feb; 16(2):473-80. PubMed ID: 19015922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncoproteins and tumor progression in papillary thyroid carcinoma: presence of epidermal growth factor receptor, c-erbB-2 protein, estrogen receptor related protein, p21-ras protein, and proliferation indicators in relation to tumor recurrences and patient survival.
    Akslen LA; Varhaug JE
    Cancer; 1995 Nov; 76(9):1643-54. PubMed ID: 8635070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total vs hemithyroidectomy for intermediate risk papillary thyroid cancer: A 23 year retrospective study in a tertiary center.
    Tsui KP; Kwan WY; Chow TL
    Am J Otolaryngol; 2019; 40(3):431-434. PubMed ID: 30956005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of routine ultrasonography follow-up after total thyroidectomy in patients with papillary thyroid carcinoma: a single-center study.
    Park HK; Kim DW; Ha TK; Heo YJ; Baek JW; Lee YJ; Cho YJ; Lee DK; Kim DH; Jung SJ; Ahn KJ; Ahn HS; Baek HJ
    BMC Med Imaging; 2018 May; 18(1):12. PubMed ID: 29764382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Tumor Cells Enriched by the Depletion of Leukocytes with Bi-Antibodies in Non-Small Cell Lung Cancer: Potential Clinical Application.
    Yin J; Wang Y; Yin H; Chen W; Jin G; Ma H; Dai J; Chen J; Jiang Y; Wang H; Liu Z; Hu Z; Shen H
    PLoS One; 2015; 10(8):e0137076. PubMed ID: 26317979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.